More Bang For Your Becquerel A Novel Approach to Dosing in 177Lu-PSMA Radioligand Therapy
2025 EANM
Tumour Dosimetry - It's a Grey Area: Analysing the Importance of Lesion Level Dosimetry Methods in 177Lu-PSMA Targeted Therapy
2025 EANM
Modelling absorbed doses to tumors and at-risk organs from a novel PSMA-targeted radioligand labeled with Actinium-225
2025 SNMMI mid-winter meeting
Preclinical evaluation of 225Ac-rhPSMA-10.1, a novel radiohybrid PSMA compound for targeted alpha therapy of prostate cancer
2023 EANM Meeting
Enhanced therapeutic response to 177Lu-rhPSMA-10.1 in pre-clinical models of prostate cancer
2023 SNMMI Meeting
